Disruption of the SHH pathway causes a range of well-characterized phenotypes, including holoprosencephaly, cerebellar hypoplasia, heart defects, skeletal abnormalities, and cancers such as medulloblastoma and basal cell carcinoma. This evidence concerns the gene SHH and medulloblastoma.